![Foto de Marta](/img/nophoto.png)
Marta
Ruiz Ortega
Publications dans lesquelles il/elle collabore avec Marta Ruiz Ortega (11)
2023
-
B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease
Clinical science (London, England : 1979), Vol. 137, Núm. 17, pp. 1409-1429
-
IMPROVE-PD Finder: A Web-Based Platform to Search and Share Peritoneal Dialysis Biobank, Registry, and Clinical Trial Metadata
Kidney International Reports, Vol. 8, Núm. 4, pp. 912-915
2021
-
Interleukin-17A: Potential mediator and therapeutic target in hypertension
Nefrologia
-
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257
2020
-
IL‐17A as a potential therapeutic target for patients on peritoneal dialysis
Biomolecules, Vol. 10, Núm. 10, pp. 1-36
-
Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis
Nature Communications, Vol. 11, Núm. 1
-
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease
Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 2026-2042
2018
-
Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology
Mediators of Inflammation, Vol. 2018
-
Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage
Mediators of Inflammation, Vol. 2018
2015
-
Paricalcitol inhibits aldosterone-induced proinflammatory factors by modulating epidermal growth factor receptor pathway in cultured tubular epithelial cells
BioMed Research International, Vol. 2015
2011
-
Globotriaosylsphingosine actions on human glomerular podocytes: Implications for Fabry nephropathy
Nephrology Dialysis Transplantation, Vol. 26, Núm. 6, pp. 1797-1802